|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kamat AM, Hahn NM, Efstathiou JA, Lerner
SP, Malmstrom PU, Choi W, Guo CC, Lotan Y and Kassouf W: Bladder
cancer. Lancet. 388:2796–2810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Knowles MA and Hurst CD: Molecular biology
of bladder cancer: New insights into pathogenesis and clinical
diversity. Nat Rev Cancer. 15:25–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kluth LA, Black PC, Bochner BH, Catto J,
Lerner SP, Stenzl A, Sylvester R, Vickers AJ, Xylinas E and Shariat
SF: Prognostic and prediction tools in bladder cancer: A
comprehensive review of the literature. Eur Urol. 68:238–253. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martens-Uzunova ES, Bottcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pandey GK, Mitra S, Subhash S, Hertwig F,
Kanduri M, Mishra K, Fransson S, Ganeshram A, Mondal T, Bandaru S,
et al: The risk-associated long noncoding RNA NBAT-1 controls
neuroblastoma progression by regulating cell proliferation and
neuronal differentiation. Cancer Cell. 26:722–737. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yoon JH, Abdelmohsen K and Gorospe M:
Posttranscriptional gene regulation by long noncoding RNA. J Mol
Biol. 425:3723–3730. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McCleland ML, Mesh K, Lorenzana E, Chopra
VS, Segal E, Watanabe C, Haley B, Mayba O, Yaylaoglu M, Gnad F and
Firestein R: CCAT1 is an enhancer-templated RNA that predicts BET
sensitivity in colorectal cancer. J Clin Invest. 126:639–652. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li J, Chen Z, Tian L, Zhou C, He MY, Gao
Y, Wang S, Zhou F, Shi S, Feng X, et al: LncRNA profile study
reveals a three-lncRNA signature associated with the survival of
patients with oesophageal squamous cell carcinoma. Gut.
63:1700–1710. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu Y, Wang J, Qian J, Kong X, Tang J, Wang
Y, Chen H, Hong J, Zou W, Chen Y, et al: Long noncoding RNA GAPLINC
regulates CD44-dependent cell invasiveness and associates with poor
prognosis of gastric cancer. Cancer Res. 74:6890–6902. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang P, Chen T, Xu Z, Zhu H, Wang J and He
Z: Long noncoding RNA GAPLINC promotes invasion in colorectal
cancer by targeting SNAI2 through binding with PSF and NONO.
Oncotarget. 7:42183–42194. 2016.PubMed/NCBI
|
|
15
|
Paner GP, Stadler WM, Hansel DE, Montironi
R, Lin DW and Amin MB: Updates in the eighth edition of the
tumor-node-metastasis staging classification for urologic cancers.
Eur Urol. 8:31064–31073. 2018.
|
|
16
|
Li J, Han L, Roebuck P, Diao L, Liu L,
Yuan Y, Weinstein JN and Liang H: TANRIC: An interactive open
platform to explore the function of lncRNAs in cancer. Cancer Res.
75:3728–3737. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang
Y, Tang GN, Zhou WP and Sun SH: Hepatitis B virus X protein
(HBx)-related long noncoding RNA (lncRNA) down-regulated expression
by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by
targeting the intermediate filament protein vimentin. Hepatology.
57:1882–1892. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, He L, Du Y, Zhu P, Huang G, Luo J,
Yan X, Ye B, Li C, Xia P, et al: The long noncoding RNA lncTCF7
promotes self-renewal of human liver cancer stem cells through
activation of Wnt signaling. Cell Stem Cell. 16:413–425. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mehra R, Udager AM, Ahearn TU, Cao X, Feng
FY, Loda M, Petimar JS, Kantoff P, Mucci LA and Chinnaiyan AM:
Overexpression of the long non-coding RNA SChLAP1 independently
predicts lethal prostate cancer. Eur Urol. 70:549–552. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu L, Zhao X, Zou H, Bai R, Yang K and
Tian Z: Hypoxia promotes gastric cancer malignancy partly through
the HIF-1α dependent transcriptional activation of the long
non-coding RNA GAPLINC. Front Physiol. 7:4202016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feitelson MA, Arzumanyan A, Kulathinal RJ,
Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML,
Nawroth R, Sanchez-Garcia I, et al: Sustained proliferation in
cancer: Mechanisms and novel therapeutic targets. Semin Cancer
Biol. 35 Suppl:S25–S54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Olsson AY, Feber A, Edwards S, Poele Te R,
Giddings I, Merson S and Cooper CS: Role of E2F3 expression in
modulating cellular proliferation rate in human bladder and
prostate cancer cells. Oncogene. 26:1028–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jirawatnotai S, Sharma S, Michowski W,
Suktitipat B, Geng Y, Quackenbush J, Elias JE, Gygi SP, Wang YE and
Sicinski P: The cyclin D1-CDK4 oncogenic interactome enables
identification of potential novel oncogenes and clinical prognosis.
Cell Cycle. 13:2889–2900. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kastan MB and Bartek J: Cell-cycle
checkpoints and cancer. Nature. 432:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pei XH, Bai F, Tsutsui T, Kiyokawa H and
Xiong Y: Genetic evidence for functional dependency of p18Ink4c on
Cdk4. Mol Cell Biol. 24:6653–6664. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gontero P, Banisadr S, Frea B and Brausi
M: Metastasis markers in bladder cancer: A review of the literature
and clinical considerations. Eur Urol. 46:296–311. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jacobs BL, Lee CT and Montie JE: Bladder
cancer in 2010: How far have we come? CA Cancer J Clin. 60:244–272.
2010. View Article : Google Scholar : PubMed/NCBI
|
